Back to search

Article

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas

2026-06-21

Abstract excerpt

Immunotherapy approaches have shown limited efficacy in pediatric sarcomas, partly because these tumors have low mutation burden and few neoantigens. We sought to increase the immunogenicity of low mutation sarcomas by inducing expression of epigenetically silenced genes using the hypomethylating agent decitabine and histone deacetylase inhibitor entinostat. Using a mutated Kras-driven murine sarcoma model KP Sarc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c224fb22-0c48-5be5-aa96-eaae683395f5
DOI
10.64898/2026.06.18.733244
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomasDOI 10.64898/2026.06.18.733244
Select a neighboring publication to make it the new centre.